[1,2,4]Triazolo[1,5-a]pyridin-7-ol

Catalog No. :
ACKTBX725
CAS No. :
1033810-70-6
Molecular Formula :
C6H5N3O
Molecular Weight :
135.13

IUPAC Name:[1,2,4]triazolo[1,5-a]pyridin-7-ol

[1,2,4]Triazolo[1,5-a]pyridin-7-ol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$56.00Login to see priceIn stockInquiry
10g95%$108.00Login to see priceIn stockIn stock
25g95%$223.00Login to see priceIn stockIn stock
100g95%$711.00Login to see priceIn stockIn stock
500g95%$2673.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name[1,2,4]Triazolo[1,5-a]pyridin-7-ol
IUPAC Name[1,2,4]triazolo[1,5-a]pyridin-7-ol
MDL No.MFCD22394734
Molecular FormulaC6H5N3O
Molecular Weight135.13
SMILESOC1=CC2=NC=NN2C=C1
InChI KeyDZFUIMCPDRBQHY-UHFFFAOYSA-N
SynonymSB21234 | A896476 | CS-0084736 | SCHEMBL1192186 | AS-61710 | [1,2,4]-triazolo[1,5-a]pyridin-7-ol | [1,2,4]triazolo[1,5-a]pyridin-7-ol | MFCD22394734 | AKOS023556544 | 3H-[1,2,4]triazolo[1,5-a]pyridin-7-one | SY056792 | EN300-1592193 | DZFUIMCPDRBQHY-UHFFF
CAS No.1033810-70-6
PubChem CID66937011

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACKTBX725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFGXT591 route compound structure diagram
    ACFGXT5911053655-66-5 In Stock
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Then
  5. ACKTBX725 route product structure diagram
    ACKTBX7251033810-70-6 In Stock
Inquiry

2. ACKTBX725 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKTBX725 route product structure diagram
    ACKTBX7251033810-70-6 In Stock
Inquiry

Comments (0)